3648 results for «2581»

Filter By

3648 results

Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award

20 May 2026 – From EuroPCR 2026

The Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award session celebrates outstanding contributions to cardiovascular research and innovation. It highlights achievements by emerging investigators, recognizing excellence that advances the field of cardiology and inspires future clinical and scientific endeavors.

Jon DeHaan Foundation Award & Michele Pighi Young Investigator Award

PCR's Got Talent Award, best abstract & best case Awards

22 May 2026 – From EuroPCR 2026

This session celebrates excellence in interventional cardiology through the PCR's Got Talent Award, highlighting the best abstracts and case presentations. It showcases innovative research and exemplary clinical cases that advance the field, fostering professional recognition and knowledge dissemination.

PCR's Got Talent Award, best abstract & best case Awards

Personalised Vascular Care Award - Ceremony

20 May 2026 – From EuroPCR 2026

The Personalised Vascular Care Award Ceremony celebrated outstanding achievements in the advancement of personalized vascular treatment approaches, recognizing leaders who have contributed significantly to improving patient outcomes in vascular care.

Personalised Vascular Care Award - Ceremony

EuroPCR 2026 Closing Ceremony

22 May 2026 – From EuroPCR 2026

The EuroPCR 2026 Closing Ceremony marks the conclusion of this premier cardiology event, celebrating the latest advances and achievements in interventional cardiology. It offers an opportunity to reflect on the educational sessions, network with peers, and recognize outstanding contributions to the field.

EuroPCR 2026 Closing Ceremony

Welcome to EuroPCR 2026

19 May 2026 – From EuroPCR 2026

Welcome to EuroPCR 2026, the premier event for interventional cardiology professionals. This edition offers cutting-edge scientific presentations, live cases, and interactive sessions designed to advance knowledge and clinical practice in cardiovascular interventions.

Welcome to EuroPCR 2026

Mastering complex TAVI: achieving optimal outcomes with Evolut FX+

20 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session focuses on advancing the management of complex transcatheter aortic valve implantation (TAVI) procedures using Evolut FX+ technology.

It highlights the benefits of supra-annular TAVI in patients with severe bicuspid aortic stenosis, supported by a review of available clinical evidence.

Through a series of case-based...

Mastering complex TAVI: achieving optimal outcomes with Evolut FX+

PRISM-PCI - From clarity to cure

20 May 2026 – From EuroPCR 2026

PRISM-PCI offers cutting-edge imaging innovations and treatment strategies aimed at optimizing complex PCI procedures. This session explores the 'leave nothing behind' concept with thin-strut bioresorbable scaffolds and sirolimus drug-coated balloons, updates on ultra thin-strut DES platforms, including the SORT OUT XII trial, and introduces a comprehensive...

PRISM-PCI - From clarity to cure

IBERIS: the first radial renal denervation (RDN) system for the treatment of uncontrolled hypertension

20 May 2026 – From EuroPCR 2026

This session introduces the IBERIS system, the first radial-access platform for renal denervation in patients with uncontrolled hypertension. It covers patient selection, procedural planning, and key technical considerations for both transfemoral and transradial approaches. A LIVE case demonstration highlights essential procedural steps while addressing the clinical...

IBERIS: the first radial renal denervation (RDN) system for the treatment of uncontrolled hypertension

The continuum of valvular heart disease: a lifetime management approach

21 May 2026 – From EuroPCR 2026

This session offers a comprehensive perspective on valvular heart disease through the lens of lifetime management, highlighting the need for strategic planning across aortic, mitral, and tricuspid interventions, illustrating how treating one valve can influence the progression and management of others. Gain insights into optimal timing...

The continuum of valvular heart disease: a lifetime management approach

Navigating high-thrombus burden in ACS: precision aspiration thrombectomy with CAT RX

21 May 2026 – From EuroPCR 2026

This session explores the challenges of managing high thrombus burden in patients with acute coronary syndromes (ACS), with a focus on precision aspiration thrombectomy using the CAT RX device. Through case-based examples, it provides practical insights into procedural techniques and examines the role of CAT RX...

Navigating high-thrombus burden in ACS: precision aspiration thrombectomy with CAT RX

Is durability still a topic of concern for TAVI patients? What are the remaining challenges that we need to overcome?

20 May 2026 – From EuroPCR 2026

Examine the clinical relevance of TAVI valve durability and its impact on long-term patient management in aortic stenosis. Review key factors influencing valve performance over time, with a focus on procedural and anatomical determinants of optimal outcomes.

Current concepts and techniques aimed at achieving ideal valve expansion...

Is durability still a topic of concern for TAVI patients? What are the remaining challenges that we need to overcome?

TAVI vs. surgery - Are the latest long-term data creating a dilemma for aortic stenosis patients?

21 May 2026 – From EuroPCR 2026

This session critically evaluates the latest long-term data comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR). It explores differing perspectives between surgeons and interventional cardiologists regarding valve durability and lifetime management, fostering a high-quality debate to achieve consensus within Heart Team discussions...

TAVI vs. surgery - Are the latest long-term data creating a dilemma for aortic stenosis patients?

CathWorks FFRangio: from clinical data to advanced patient care

21 May 2026 – From EuroPCR 2026

Explore the clinical value of the CathWorks FFRangio system through the lens of the ALL-RISE randomised controlled trial and its implications for daily practice. By reviewing the trial’s primary and secondary endpoints, examine how FFRangio may influence diagnostic assessment, treatment planning, and clinical decision-making in patients...

CathWorks FFRangio: from clinical data to advanced patient care

Real world practice inspiring new evidence generation in structural heart

21 May 2026 – From EuroPCR 2026

This LIVE case session showcases real-world clinical practice driving new evidence in structural heart interventions, with a focus on TAVI. It features expert insights into pre-procedural imaging and sizing, treatment strategies, procedural techniques, and post-procedural management. The session also introduces the novel Myval Octapro+ transcatheter heart...

Real world practice inspiring new evidence generation in structural heart

Renal denervation in China: momentum, insights, and evolution

21 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session highlights the rapidly evolving clinical experience of renal denervation (RDN) in China following regulatory approval, with a focus on real-world practice and programme development.

It reviews how structured, patient-centred hypertension pathways are being integrated with RDN, alongside practical strategies for managing complex renal...

Renal denervation in China: momentum, insights, and evolution

Pulmonary embolism intervention: a turning point in defining success

21 May 2026 – From EuroPCR 2026

This session explores the evolving objectives of pulmonary embolism treatment, highlighting the shift from simple patient stabilisation to a more comprehensive approach to recovery. It introduces the novel Transforming Fixation (TFX) technology and its role in improving catheter stability and access to the pulmonary vasculature. Drawing...

Pulmonary embolism intervention: a turning point in defining success

The metal-free strategy: shaping the new era of hybrid vessel restoration with DCB and BRS

19 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session explores the emerging metal-free strategy in coronary intervention, combining drug-coated balloons (DCB) and bioresorbable scaffolds (BRS) to support a “leave-nothing-behind” approach to vessel restoration.

It focuses on lesion preparation, scaffold sizing and deployment, and the integration of hybrid therapies to optimise procedural outcomes....

The metal-free strategy: shaping the new era of hybrid vessel restoration with DCB and BRS

Rethinking stentless PCI strategy - Improving outcomes with Bioadaptor

19 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session explores contemporary PCI strategies through the concept of stentless intervention using the Bioadaptor device in complex coronary disease.

It highlights the bioadaptive design features of Bioadaptor and reviews the supporting clinical evidence, with a focus on how this technology may influence procedural outcomes.

The...

Rethinking stentless PCI strategy - Improving outcomes with Bioadaptor

Disrupting the aorta and valves: the next transcatheter wave

18 May 2026 – From EuroPCR 2026

Delve into the next wave of transcatheter interventions disrupting the aorta and valves. This session covers pioneering minimally invasive ascending aortic repair, novel polymeric aortic valve implants, and innovative devices for tricuspid repair and leaflet replacement.

How to become a CHAMPION in LAA closure

19 May 2026 – From EuroPCR 2026

This session reviews the latest CHAMPION AF trial data and its implications for left atrial appendage (LAA) closure in patients with atrial fibrillation.

It explores how emerging evidence may influence clinical practice and patient selection, and how LAA closure could evolve across different atrial fibrillation populations. 

A recorded...

How to become a CHAMPION in LAA closure
Didn’t find what you were looking for?